Can the keto diet influence brain cancer? Clinical and Research Neurologist Dr Matthew Philips spoke at the Future of Medicine Conference 2023, about his research into utilising fasting and low-carb, high-fat ketogenic diets to help those with glioblastoma.

About Dr Matthew Phillips
Dr Matthew Phillips is a highly respected neurologist based at Waikato Hospital in Hamilton, New Zealand. With a strong passion for exploring the potential benefits of metabolic therapies for neurological disorders, he has made significant contributions to the field of neurology through his pioneering research into fasting and ketogenic diets.

As a full-time clinician, Dr Phillips has firsthand experience treating patients with a variety of difficult neurological conditions, including Parkinson’s and Alzheimer’s. Through his research, he has sought to develop alternate metabolic states that may improve not only the symptoms but also the function and quality of life for these patients.

Dr Phillips’ groundbreaking work has earned him international recognition and acclaim. In 2017-2018, his team conducted a world-first randomised controlled study of a ketogenic diet in Parkinson’s disease, providing compelling evidence for the therapeutic potential of this approach.

About the Future of Medicine
The Future of Medicine is a ground-up movement, challenging the status quo in our current ‘sick care’ system, and shifting the narrative from “bottom-of-the-cliff” stopgaps to sustainable proactive preventions and lifestyle interventions. Join the movement at https://thefutureofmedicine.co/.

The Future of Medicine is powered by PREKURE, Australasia’s leading provider of university-level training in preventative lifestyle medicine for individuals and professionals.
https://prekure.com/